Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tissue Atrophy in Early Alzheimer's Disease

Manuscript Number: 

21-0503R3

Author(s): 
Andrew J. Aschenbrenner, Tammie LS Benzinger, Anne M. Fagan, Manu S. Goyal, Charles F. Hildebolt, Satya V.V.N. Kothapalli, John C. Morris, Richard J. Perrin, Marcus E. Raichle, Dmitriy A. Yablonskiy

Disclosures

Andrew J. Aschenbrenner

  • Nothing to Disclose

Tammie LS Benzinger

  • Consulting Fees:
    Biogen MRI advisory board, funds paid to me.
    Lecture Fees:
    Biogen, funds paid to me.

Anne M. Fagan

  • Consulting Fees:
    Advisory Board membership for Roche Diagnostics, Genentech, Diadem. Consults for DiamiR and Seimens Healthcare Diagnostics Inc
    Grants
    • Agency: 
      Centene
      Dates: 
      2019-present

Manu S. Goyal

  • Equity:
    IBM, Moderna, BioNTech

Charles F. Hildebolt

  • Nothing to Disclose

Satya V.V.N. Kothapalli

  • Nothing to Disclose

John C. Morris

  • Nothing to Disclose

Richard J. Perrin

  • Nothing to Disclose

Marcus E. Raichle

  • Nothing to Disclose

Dmitriy A. Yablonskiy

  • Nothing to Disclose